New clue found in how immune cells work together to fight breast cancer

Researchers have identified a previously understudied partnership between two types of immune cells—eosinophils and T cells—that appears to influence how well breast cancer patients respond to immunotherapy. The finding could help oncologists predict which patients will benefit from current treatments and guide development of next-generation therapies.

Originaltitel: The interplay between eosinophils and T cells in breast cancer immunotherapy